Glutamate transporter-1 (GLT-1): a potential therapeutic target for the treatment of central nervous system diseases and disorders

2017 ◽  
Vol 42 (8) ◽  
pp. 489
Author(s):  
M. Abou-Gharbia ◽  
B. Blass ◽  
W. Childers ◽  
M. Ramanjulu ◽  
E. Melenski
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Therapeutic Target ◽  
Glutamate Transporter ◽  
Nervous System Diseases ◽  
Central Nervous System Diseases ◽  
Potential Therapeutic Target ◽  
Glutamate Transporter 1

Dimephosphone — vasoactive drug for normalization of nervous system function

1993 ◽  
Vol 74 (1) ◽  
pp. 8-12
Author(s):  
R. Kh. Khafizyaiiova ◽  
I. A. Studentsova ◽  
V. I. Danilov ◽  
I. S. Mokrinskaya ◽  
R. A. Garaev ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Experimental Study ◽  
Nervous System ◽  
Cerebral Circulation ◽  
Vasoactive Drug ◽  
System Function ◽  
Nervous System Diseases ◽  
Central Nervous System Diseases ◽  
Clinical Tests ◽  
Nervous System Function

An experimental study of dimephpsphone, using different models of the disorders of cerebrum and cerebral circulation functions, reveals cerebroprotcctive properties and normalizing type of the effect on the regulating mechanisms of cerebral circulation. Clinical tests indicate the efficacy of the drug in different central nervous system diseases in neurological and neurosurgical clinics.

Trans Neuronal Retrograde Degeneration to OCT in Central Nervous System Diseases

2020 ◽  
pp. 365-374
Author(s):  
Bernardo F. Sánchez-Dalmau ◽  
Anna Camós-Carreras ◽  
Ruben Torres-Torres ◽  
Johannes Keller ◽  
Laura Sanchez-Vela ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Nervous System Diseases ◽  
Central Nervous System Diseases ◽  
Retrograde Degeneration
Sign in / Sign up

Export Citation Format

Share Document